Skip to main content
. 2021 Aug 13;16:5479–5494. doi: 10.2147/IJN.S313339

Figure 3.

Figure 3

(A) Particle size; (B) zeta potential of PTX-siRNAVEGF-NPs (N/P = 30, C/N = 1/5; PTX content of 6.04%); (C) gel electrophoresis assay for (a) siRNAVEGF-NPs and (b) PTX-siRNAVEGF-NPs (N/P = 30, C/N = 1/5; PTX content of 6.04%); (D) time-dependent colloidal stability of PTX-siRNAVEGF-NPs in PBS or PBS containing 10% FBS at 37°C.